That’s Nice serves 300 marketing clients in the materials science and life science industries. The company is investing $2.5 million into its new Nice Insight brand, encompassing the design and deployment of the Pharmaceutical & Biotechnology Outsourcing Survey that will solicit input from up to 40,000 respected industry professionals, and collection and analysis of visual and messaging strategies employed by 400+ CRAMs companies.
This degree of commitment and investment will deliver two robust core product offerings, called ‘Marcom Tracker’ and ‘Brand Index,’ which will provide a level of marketing intelligence not currently available to companies in the Contract Research & Manufacturing (CRAMs) sector. The products will also benefit any company seeking to partner with the industry’s innovators and developers.
Victor Coker, Director of Business Intelligence, said, “CRAMs and innovator companies need a practical and personalized evaluation of the market to enable them to more effectively align their communications and services with their potential partners. This is the only way to improve collaborations and enhance the prospective pipeline for life-changing drugs. While working in CRAMs, I was unable to access intelligence in this depth and format, so we’re very excited about Nice Insight.”
The 40,000 industry professionals canvassed in the Pharmaceutical & Biotechnology Outsourcing Survey represent Big Pharma, Mid-size Pharma, Virtual and Emerging Companies, and Small Biotechs. The Brand Index product consequently offers focused insight into innovator & investor perceptions of CRAMs providers and highlights the current needs of potential research and development partners.
Marcom Tracker is a visual brand research process. Nice Insight collects and analyzes public domain visual presentations and marketing strategies employed by 400+ CRAMs companies, with quarterly tracking so the intelligence remains current. This gives companies an unequalled frame of reference for evaluation of their own strategy if they are investing in rebranding or simply measuring their marketing communications.
